Cargando…
Assessment of adjuvantation strategy of lipid squalene nanoparticles for enhancing the immunogenicity of a SARS-CoV-2 spike subunit protein against COVID-19
Vaccination is regarded as the most effective intervention for controlling the coronavirus disease 2019 (COVID-19) pandemic. The objective of this study is to provide comprehensive information on lipid squalene nanoparticle (SQ@NP)-adjuvanted COVID-19 vaccines regarding modulating immune response an...
Autores principales: | Ho, Hui-Min, Huang, Chiung-Yi, Cheng, Yu-Jhen, Shen, Kuan-Yin, Tzeng, Tsai-Teng, Liu, Shih-Jen, Chen, Hsin-Wei, Huang, Chung-Hsiung, Huang, Ming-Hsi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372419/ https://www.ncbi.nlm.nih.gov/pubmed/34416331 http://dx.doi.org/10.1016/j.ijpharm.2021.121024 |
Ejemplares similares
-
Formulation of SARS-CoV-2 Spike Protein with CpG Oligodeoxynucleotides and Squalene Nanoparticles Modulates Immunological Aspects Following Intranasal Delivery
por: Ho, Hui-Min, et al.
Publicado: (2022) -
Nanoemulsion adjuvantation strategy of tumor-associated antigen therapy rephrases mucosal and immunotherapeutic signatures following intranasal vaccination
por: Huang, Chung-Hsiung, et al.
Publicado: (2020) -
Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex
por: Turbyfill, K. Ross, et al.
Publicado: (2018) -
Adjuvants and adjuvanticity
por: Tizard, Ian R.
Publicado: (2021) -
RNA is an Adjuvanticity Mediator for the Lipid-Based Mucosal Adjuvant, Endocine
por: Hayashi, Masayuki, et al.
Publicado: (2016)